Cargando…
Observational Study of Metformin and Risk of Mortality in Patients Hospitalized with Covid-19
IMPORTANCE: Type 2 diabetes (T2DM) and obesity are significant risk factors for mortality in Covid19. Metformin has sex specific immunomodulatory effects which may elucidate treatment mechanisms in COVID-19. OBJECTIVE: We sought to identify whether metformin reduced mortality from Covid19 and if sex...
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7325185/ https://www.ncbi.nlm.nih.gov/pubmed/32607520 http://dx.doi.org/10.1101/2020.06.19.20135095 |
_version_ | 1783552103374913536 |
---|---|
author | Bramante, Carolyn T. Ingraham, Nicholas E. Murray, Thomas A. Marmor, Schelomo Hovertsen, Shane Gronski, Jessica McNeil, Chace Feng, Ruoying Guzman, Gabriel Abdelwahab, Nermine King, Samantha Meehan, Thomas Pendleton, Kathryn M. Benson, Bradley Vojta, Deneen Tignanelli, Christopher J. |
author_facet | Bramante, Carolyn T. Ingraham, Nicholas E. Murray, Thomas A. Marmor, Schelomo Hovertsen, Shane Gronski, Jessica McNeil, Chace Feng, Ruoying Guzman, Gabriel Abdelwahab, Nermine King, Samantha Meehan, Thomas Pendleton, Kathryn M. Benson, Bradley Vojta, Deneen Tignanelli, Christopher J. |
author_sort | Bramante, Carolyn T. |
collection | PubMed |
description | IMPORTANCE: Type 2 diabetes (T2DM) and obesity are significant risk factors for mortality in Covid19. Metformin has sex specific immunomodulatory effects which may elucidate treatment mechanisms in COVID-19. OBJECTIVE: We sought to identify whether metformin reduced mortality from Covid19 and if sex specific interactions exist. DESIGN: Retrospective review of de-identified claims from UnitedHealth Group’s Clinical Discovery Database. Unadjusted and multivariate models were conducted to assess risk of mortality based on metformin and tumor necrosis factor alpha (TNFα) inhibitors as home medications in individuals with T2DM and obesity, controlling for comorbidities, medications, demographics, and state. Heterogeneity of effect was assessed by sex. SETTING: The database includes all 50 states in the United States. PARTICIPANTS: Persons with at least 6 months of continuous coverage from UnitedHealth Group in 2019 who were hospitalized with Covid-19. Persons in the metformin group had > 90 days of metformin claims in the 12 months before hospitalization. RESULTS: 6,256 persons were included; 52.8% female; mean age 75 years. Metformin was associated with decreased mortality in women by logistic regression, OR 0.792 (0.640, 0.979); mixed effects OR 0.780 (0.631, 0.965); Cox proportional-hazards: HR 0.785 (0.650, 0.951); and propensity matching, OR of 0.759 (0.601, 0.960). There was no significant reduction in mortality among men. TNFα inhibitors were associated with decreased mortality, by propensity matching in a limited model, OR 0.19 (0.0378, 0.983). CONCLUSIONS: Metformin was significantly associated with reduced mortality in women with obesity or T2DM in observational analyses of claims data from individuals hospitalized with Covid-19. This sex-specific finding is consistent with metformin’s reduction of TNFα in females over males, and suggests that metformin conveys protection in Covid-19 through TNFα effects. Prospective studies are needed to understand mechanism and causality. |
format | Online Article Text |
id | pubmed-7325185 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Cold Spring Harbor Laboratory |
record_format | MEDLINE/PubMed |
spelling | pubmed-73251852020-06-30 Observational Study of Metformin and Risk of Mortality in Patients Hospitalized with Covid-19 Bramante, Carolyn T. Ingraham, Nicholas E. Murray, Thomas A. Marmor, Schelomo Hovertsen, Shane Gronski, Jessica McNeil, Chace Feng, Ruoying Guzman, Gabriel Abdelwahab, Nermine King, Samantha Meehan, Thomas Pendleton, Kathryn M. Benson, Bradley Vojta, Deneen Tignanelli, Christopher J. medRxiv Article IMPORTANCE: Type 2 diabetes (T2DM) and obesity are significant risk factors for mortality in Covid19. Metformin has sex specific immunomodulatory effects which may elucidate treatment mechanisms in COVID-19. OBJECTIVE: We sought to identify whether metformin reduced mortality from Covid19 and if sex specific interactions exist. DESIGN: Retrospective review of de-identified claims from UnitedHealth Group’s Clinical Discovery Database. Unadjusted and multivariate models were conducted to assess risk of mortality based on metformin and tumor necrosis factor alpha (TNFα) inhibitors as home medications in individuals with T2DM and obesity, controlling for comorbidities, medications, demographics, and state. Heterogeneity of effect was assessed by sex. SETTING: The database includes all 50 states in the United States. PARTICIPANTS: Persons with at least 6 months of continuous coverage from UnitedHealth Group in 2019 who were hospitalized with Covid-19. Persons in the metformin group had > 90 days of metformin claims in the 12 months before hospitalization. RESULTS: 6,256 persons were included; 52.8% female; mean age 75 years. Metformin was associated with decreased mortality in women by logistic regression, OR 0.792 (0.640, 0.979); mixed effects OR 0.780 (0.631, 0.965); Cox proportional-hazards: HR 0.785 (0.650, 0.951); and propensity matching, OR of 0.759 (0.601, 0.960). There was no significant reduction in mortality among men. TNFα inhibitors were associated with decreased mortality, by propensity matching in a limited model, OR 0.19 (0.0378, 0.983). CONCLUSIONS: Metformin was significantly associated with reduced mortality in women with obesity or T2DM in observational analyses of claims data from individuals hospitalized with Covid-19. This sex-specific finding is consistent with metformin’s reduction of TNFα in females over males, and suggests that metformin conveys protection in Covid-19 through TNFα effects. Prospective studies are needed to understand mechanism and causality. Cold Spring Harbor Laboratory 2020-06-28 /pmc/articles/PMC7325185/ /pubmed/32607520 http://dx.doi.org/10.1101/2020.06.19.20135095 Text en https://creativecommons.org/licenses/by-nd/4.0/This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License (https://creativecommons.org/licenses/by-nd/4.0/) , which allows reusers to copy and distribute the material in any medium or format in unadapted form only, and only so long as attribution is given to the creator. The license allows for commercial use. |
spellingShingle | Article Bramante, Carolyn T. Ingraham, Nicholas E. Murray, Thomas A. Marmor, Schelomo Hovertsen, Shane Gronski, Jessica McNeil, Chace Feng, Ruoying Guzman, Gabriel Abdelwahab, Nermine King, Samantha Meehan, Thomas Pendleton, Kathryn M. Benson, Bradley Vojta, Deneen Tignanelli, Christopher J. Observational Study of Metformin and Risk of Mortality in Patients Hospitalized with Covid-19 |
title | Observational Study of Metformin and Risk of Mortality in Patients Hospitalized with Covid-19 |
title_full | Observational Study of Metformin and Risk of Mortality in Patients Hospitalized with Covid-19 |
title_fullStr | Observational Study of Metformin and Risk of Mortality in Patients Hospitalized with Covid-19 |
title_full_unstemmed | Observational Study of Metformin and Risk of Mortality in Patients Hospitalized with Covid-19 |
title_short | Observational Study of Metformin and Risk of Mortality in Patients Hospitalized with Covid-19 |
title_sort | observational study of metformin and risk of mortality in patients hospitalized with covid-19 |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7325185/ https://www.ncbi.nlm.nih.gov/pubmed/32607520 http://dx.doi.org/10.1101/2020.06.19.20135095 |
work_keys_str_mv | AT bramantecarolynt observationalstudyofmetforminandriskofmortalityinpatientshospitalizedwithcovid19 AT ingrahamnicholase observationalstudyofmetforminandriskofmortalityinpatientshospitalizedwithcovid19 AT murraythomasa observationalstudyofmetforminandriskofmortalityinpatientshospitalizedwithcovid19 AT marmorschelomo observationalstudyofmetforminandriskofmortalityinpatientshospitalizedwithcovid19 AT hovertsenshane observationalstudyofmetforminandriskofmortalityinpatientshospitalizedwithcovid19 AT gronskijessica observationalstudyofmetforminandriskofmortalityinpatientshospitalizedwithcovid19 AT mcneilchace observationalstudyofmetforminandriskofmortalityinpatientshospitalizedwithcovid19 AT fengruoying observationalstudyofmetforminandriskofmortalityinpatientshospitalizedwithcovid19 AT guzmangabriel observationalstudyofmetforminandriskofmortalityinpatientshospitalizedwithcovid19 AT abdelwahabnermine observationalstudyofmetforminandriskofmortalityinpatientshospitalizedwithcovid19 AT kingsamantha observationalstudyofmetforminandriskofmortalityinpatientshospitalizedwithcovid19 AT meehanthomas observationalstudyofmetforminandriskofmortalityinpatientshospitalizedwithcovid19 AT pendletonkathrynm observationalstudyofmetforminandriskofmortalityinpatientshospitalizedwithcovid19 AT bensonbradley observationalstudyofmetforminandriskofmortalityinpatientshospitalizedwithcovid19 AT vojtadeneen observationalstudyofmetforminandriskofmortalityinpatientshospitalizedwithcovid19 AT tignanellichristopherj observationalstudyofmetforminandriskofmortalityinpatientshospitalizedwithcovid19 |